Tsumura & Co (4540) - Financial and Strategic SWOT Analysis Review

Tsumura & Co (4540) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Tsumura & Co (Tsumura) is a traditional pharmaceuticals developer that markets Kampo extract intermediates and granular Kampo formulations. The company's product portfolio comprises a range of prescription Kampo products, over-the-counter (OTC) Kampo formulations, crude drug pieces, and raw materials for crude drugs. The company's Kampo products are used to cure diseases that are difficult to treat with western drugs such as abdominal pain and bloating, diseases specific to women, cramps, acne, muscle spasms, lower back pain, respiratory diseases, and cardiovascular diseases. The company has a business presence in the US, China, and Japan. Tsumura is headquartered in Minato-ku, Tokyo, Japan.

Tsumura & Co Key Recent Developments

May 09,2023: Tsumura Announces Consolidated Financial Results for the Fiscal Year Ended March 31, 2023
Mar 01,2023: TSUMURA USA Website has opened
Feb 03,2023: Tsumura Announces Financial Results for the Third Quarter of the Fiscal Year Ending March 2023
Jan 18,2023: Tsumura Announces Second Quarterly Report

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note:Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Tsumura & Co - Key Facts
Tsumura & Co - Key Employees
Tsumura & Co - Key Employee Biographies
Tsumura & Co - Major Products and Services
Tsumura & Co - History
Tsumura & Co - Company Statement
Tsumura & Co - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Tsumura & Co - Business Description
Geographical Segment: Domestic
Performance
Geographical Segment: Overseas
Performance
R&D Overview
Tsumura & Co - Corporate Strategy
Tsumura & Co - SWOT Analysis
SWOT Analysis - Overview
Tsumura & Co - Strengths
Tsumura & Co - Weaknesses
Tsumura & Co - Opportunities
Tsumura & Co - Threats
Tsumura & Co - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Tsumura & Co, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Tsumura & Co, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Tsumura & Co, Recent Deals Summary
Section 5 – Company’s Recent Developments
May 09, 2023: Tsumura Announces Consolidated Financial Results for the Fiscal Year Ended March 31, 2023
Mar 01, 2023: TSUMURA USA Website has opened
Feb 03, 2023: Tsumura Announces Financial Results for the Third Quarter of the Fiscal Year Ending March 2023
Jan 18, 2023: Tsumura Announces Second Quarterly Report
Jan 18, 2023: Tsumura Announces Financial Results for the Second Quarter of the Fiscal Year Ending March 2023
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Tsumura & Co, Key Facts
Tsumura & Co, Key Employees
Tsumura & Co, Key Employee Biographies
Tsumura & Co, Major Products and Services
Tsumura & Co, History
Tsumura & Co, Subsidiaries
Tsumura & Co, Key Competitors
Tsumura & Co, Ratios based on current share price
Tsumura & Co, Annual Ratios
Tsumura & Co, Annual Ratios (Cont...1)
Tsumura & Co, Annual Ratios (Cont...2)
Tsumura & Co, Interim Ratios
Tsumura & Co, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Tsumura & Co, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Tsumura & Co, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Tsumura & Co, Performance Chart (2020 - 2024)
Tsumura & Co, Ratio Charts
Tsumura & Co, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Tsumura & Co, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings